Effects of pharmacological inhibition of AMP-activated protein kinase on GLUT3 expression and the development of ischemic tolerance in astrocytes

Neuroscience Research

Volumn 84, Issue , 2014, Pages 68-71

  Iwabuchi, Sadahiro ^a,b   Kawahara, Koichi ^b   Harata, N Charles ^a  

^a UNIVERSITY OF IOWA   (United States)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

AMPK; Astrocytes; GLUT3; Ischemic tolerance

Indexed keywords

GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; GLYCOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE INHIBITOR; PROTEIN SERINE THREONINE KINASE INHIBITOR; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1; GLUCOSE; LACTATE DEHYDROGENASE; MESSENGER RNA; SLC2A3 PROTEIN, RAT; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; CELL DEATH; CELL VIABILITY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; GLUCOSE TRANSPORT; GLYCOGEN ANALYSIS; GLYCOGEN SYNTHESIS; ISCHEMIC PRECONDITIONING; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REPERFUSION; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANOXIA; ANTAGONISTS AND INHIBITORS; BRAIN CORTEX; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; RAT;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANOXIA; ASTROCYTES; CEREBRAL CORTEX; GENE EXPRESSION REGULATION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 3; L-LACTATE DEHYDROGENASE; RATS; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84908539800     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2014.04.007     Document Type: Article

References (29)

1. Amato S., Man H.Y. Bioenergy sensing in the brain: the role of AMP-activated protein kinase in neuronal metabolism, development and neurological diseases. Cell Cycle 2011, 10:3452-3460.
2. Chen J., Graham S.H., Zhu R.L., Simon R.P. Stress proteins and tolerance to focal cerebral ischemia. J. Cereb. Blood Flow Metab. 1996, 16:566-577.
3. Culmsee C., Monnig J., Kemp B.E., Mattson M.P. AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. J. Mol. Neurosci. 2001, 17:45-58.
4. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65:1-105.
5. Garcia-Gil M., Pesi R., Perna S., Allegrini S., Giannecchini M., Camici M., Tozzi M.G. 5'-Aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells. Neuroscience 2003, 117:811-820.
6. Gong J., Gong S., Zhang M., Zhang L., Hu Y., Liu Y., Li W. Cerebral ischemic preconditioning reduces glutamate excitotoxicity by up-regulating the uptake activity of GLT-1 in rats. Amino Acids 2014, (in press).
7. Ikeda M., Nakazawa T., Abe K., Kaneko T., Yamatsu K. Extracellular accumulation of glutamate in the hippocampus induced by ischemia is not calcium dependent - in vitro and in vivo evidence. Neurosci. Lett. 1989, 96:202-206.
8. Iwabuchi S., Kawahara K. Possible involvement of extracellular ATP-P2Y purinoceptor signaling in ischemia-induced tolerance of astrocytes in culture. Neurochem. Res. 2009, 34:1542-1554.
9. Iwabuchi S., Kawahara K. Functional significance of the negative-feedback regulation of ATP release via pannexin-1 hemichannels under ischemic stress in astrocytes. Neurochem. Int. 2011, 58:376-384.
10. Iwabuchi S., Kawahara K. Inducible astrocytic glucose transporter-3 contributes to the enhanced storage of intracellular glycogen during reperfusion after ischemia. Neurochem. Int. 2011, 59:319-325.
11. Iwabuchi S., Kawahara K. Extracellular ATP-prinoceptor signaling and AMP-activated protein kinase regulate astrocytic glucose transporter 3 in an in vitro ischemia. Neurochem. Int. 2013, 63:259-268.
12. Jung J.E., Lee J., Ha J., Kim S.S., Cho Y.H., Baik H.H., Kang I. 5-Aminoimidazole-4-carboxamide-ribonucleoside enhances oxidative stress-induced apoptosis through activation of nuclear factor-kappaB in mouse Neuro 2a neuroblastoma cells. Neurosci. Lett. 2004, 354:197-200.
13. Kawahara K., Kosugi T., Tanaka M., Nakajima T., Yamada T. Reversed operation of glutamate transporter GLT-1 is crucial to the development of preconditioning-induced ischemic tolerance of neurons in neuron/astrocyte co-cultures. Glia 2005, 49:349-359.
14. Kitagawa K., Matsumoto M., Tagaya M., Hata R., Ueda H., Niinobe M., Handa N., Fukunaga R., Kimura K., Mikoshiba K., et al. 'Ischemic tolerance' phenomenon found in the brain. Brain Res. 1990, 528:21-24.
15. Kosugi T., Kawahara K. Reversed actrocytic GLT-1 during ischemia is crucial to excitotoxic death of neurons, but contributes to the survival of astrocytes themselves. Neurochem. Res. 2006, 31:933-943.
16. Maher F., Davies-Hill T.M., Simpson I.A. Substrate specificity and kinetic parameters of GLUT3 in rat cerebellar granule neurons. Biochem. J. 1996, 315(Pt 3):827-831.
17. Mitani A., Tanaka K. Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1. J. Neurosci. 2003, 23:7176-7182.
18. Nakajima T., Iwabuchi S., Miyazaki H., Okuma Y., Inanami O., Kuwabara M., Nomura Y., Kawahara K. Relationship between the activation of cyclic AMP responsive element binding protein and ischemic tolerance in the penumbra region of rat cerebral cortex. Neurosci. Lett. 2002, 331:13-16.
19. Nakajima T., Iwabuchi S., Miyazaki H., Okuma Y., Kuwabara M., Nomura Y., Kawahara K. Preconditioning prevents ischemia-induced neuronal death through persistent Akt activation in the penumbra region of the rat brain. J. Vet. Med. Sci. 2004, 66:521-527.
20. Nakatsu Y., Kotake Y., Hino A., Ohta S. Activation of AMP-activated protein kinase by tributyltin induces neuronal cell death. Toxicol. Appl. Pharmacol. 2008, 230:358-363.
21. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996, 16:675-686.
22. Sofroniew M.V., Vinters H.V. Astrocytes: biology and pathology. Acta Neuropathol. 2010, 119:7-35.
23. Sorokin S.P., Hoyt R.F. PAS-lead hematoxylin as a stain for small-granule endocrine cell populations in the lungs, other pharyngeal derivatives and the gut. Anat. Rec. 1978, 192:245-259.
24. Stagliano N.E., Perez-Pinzon M.A., Moskowitz M.A., Huang P.L. Focal ischemic preconditioning induces rapid tolerance to middle cerebral artery occlusion in mice. J. Cereb. Blood Flow Metab. 1999, 19:757-761.
25. Szatkowski M., Barbour B., Attwell D. Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature 1990, 348:443-446.
26. Toyoda T., Kassell N.F., Lee K.S. Induction of ischemic tolerance and antioxidant activity by brief focal ischemia. Neuroreport 1997, 8:847-851.
27. Verkhratsky A., Rodriguez J.J., Parpura V. Astroglia in neurological diseases. Future Neurol. 2013, 8:149-158.
28. Vilchez D., Ros S., Cifuentes D., Pujadas L., Valles J., Garcia-Fojeda B., Criado-Garcia O., Fernandez-Sanchez E., Medrano-Fernandez I., Dominguez J., Garcia-Rocha M., Soriano E., Rodriguez de Cordoba S., Guinovart J.J. Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. Nat. Neurosci. 2007, 10:1407-1413.
29. Weisova P., Concannon C.G., Devocelle M., Prehn J.H., Ward M.W. Regulation of glucose transporter 3 surface expression by the AMP-activated protein kinase mediates tolerance to glutamate excitation in neurons. J. Neurosci. 2009, 29:2997-3008.